Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physical and functional interaction between wild-type p53 and mdm2 proteins

D S Haines1, J E Landers, L J Engle

  • 1Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia 19104.

Molecular and Cellular Biology
|February 1, 1994
PubMed
Summary

The mdm2 oncogene produces multiple protein forms. Three forms inhibit p53 activity by binding to it, while a fourth lacks this ability, highlighting the importance of the N-terminal domain for mdm2-p53 interaction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A loss of FUS/TLS function leads to impaired cellular proliferation.

Cell death & disease·2014
Same author

Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics·2011
Same author

A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.

Oncogene·2010
Same author

Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort.

Neurology·2009
Same author

A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.

Neurology·2009
Same author

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.

Science (New York, N.Y.)·2009

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • The mdm2 oncogene is amplified in mammalian tumors.
  • mdm2 overexpression can activate transforming potential and inhibit p53.
  • Multiple mdm2 transcripts encode distinct protein forms with potentially different functions.

Purpose of the Study:

  • To investigate functional differences among naturally occurring murine mdm2 protein forms.
  • To determine the ability of different mdm2 forms to inhibit p53-mediated transcriptional activation.

Main Methods:

  • Transient transfection assays were used.
  • Four naturally occurring murine mdm2 forms were evaluated.
  • Reporter genes regulated by p53 response elements were utilized.

Related Experiment Videos

Main Results:

  • Three of the four mdm2 forms physically associated with wild-type p53.
  • These three mdm2 forms inhibited p53's transactivation function.
  • A fourth mdm2 form, lacking the N-terminal domain, did not associate with p53 or inhibit its function.

Conclusions:

  • The N-terminal domain of mdm2 is critical for p53 protein complex formation.
  • Functional differences exist among mdm2 protein products.
  • Understanding individual mdm2 protein properties is crucial for elucidating mdm2 gene function in growth control.